foto
LATEST NEWS

 OctoPlus announces 2010 first half-year results



WEBCAST HALF-YEAR RESULTS

Click here to access the webcast of 6 August 2010



OCTOPLUS OPENED NYSE EURONEXT

In celebration of OctoPlus' 15 year anniversday, CEO Simon Sturge and CFO Susan Swarte opened the financial markets in Amsterdam on Tuesday 27 July



OCTOPLUS ANNUAL REPORT 2009
VIEW OUR WEB SEMINARS
OCTO SHARE PRICE
HOME dashNL dash CONTACT

 

FORMULATION DEVELOPMENT

 

Visit us at ICSE / CPHI in Paris. 
Request your appointment here.

OctoPlus offers special formulation and manufacturing expertise in the following areas: 

Our partners turn to OctoPlus for tailor-made pharmaceutical development, specialized expertise on formulation and for difficult-to-formulate compounds and extraordinary formulations.

For more information about our formulation development and clinical manufacturing services, please refer to our in-depth technical factsheets.